This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Pancreas
CD2_BENIGN_PANCREAS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum pancreatis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Pancreas
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Pancreas
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 857 | 490 | 367 |
| Unadjusted period prevalence (%) | 0.16 | 0.17 | 0.16 |
| Median age at first event (years) | 69.48 | 68.35 | 71.00 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 715
- Matched controls
- 7149
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
211.1
323.0
343
31
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
+∞
323.0
704
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
54.7
103.8
123
27
130
Kela drug reimbursment
Malignant tumour
+∞
100.4
94
*
A09AA02
ATC
multienzymes (lipase, protease etc.)
43.0
95.7
119
33
K86.2
ICD-10 Finland
Cyst of pancreas
69.7
89.6
102
17
WX302
NOMESCO Finland
Thoracal epidural anesthesy
26.1
83.0
117
53
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
58.8
82.9
97
19
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
30.0
82.6
112
44
JLC30
NOMESCO Finland
Pancreatoduodenectomy
759.6
71.4
69
*
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
124.9
64.0
68
6
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
22.3
63.8
94
48
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
62.4
59
*
JLC10
NOMESCO Finland
Distal pancreatectomy
639.1
60.7
59
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
59.2
56
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
57.0
54
*
WZC30
NOMESCO Finland
Teaching
6.2
56.6
168
335
A04AA02
ATC
granisetron; systemic, transdermal
+∞
56.0
53
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
54.9
52
*
H02AB02
ATC
dexamethasone; systemic
31.1
54.7
73
26
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
53.0
53.0
63
13
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
75.6
49.8
56
8
XX3DW
NOMESCO Finland
Time consuming IT work
9.0
48.5
108
139
115
Kela drug reimbursment
Breast cancer
+∞
45.3
43
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
12.5
44.6
82
73
A03FA01
ATC
metoclopramide; systemic, rectal
4.6
43.6
172
462
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
13.3
43.2
77
64
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
442.3
42.6
42
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
81.9
41.4
46
6
L01BC06
ATC
capecitabine; oral
+∞
41.0
39
*
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
+∞
41.0
39
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.0
40.1
329
1574
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
38.9
37
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.2
38.3
98
155
JN4BD
NOMESCO Finland
Extensive body CT
6.9
38.1
100
164
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
102.9
36.1
39
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.6
35.9
136
345
UJK02
NOMESCO Finland
ERCP
11.8
34.7
65
60
B01AB10
ATC
tinzaparin; parenteral
6.9
33.8
88
142
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
33.6
32
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
33.6
32
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
33.6
32
*
JN4CD
NOMESCO Finland
Very extensive body CT
13.0
33.0
59
49
ZX120
NOMESCO Finland
Intravenous
4.9
31.6
112
263
116
Kela drug reimbursment
Prostate cancer
+∞
31.5
30
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.9
30.9
108
250
WF002
NOMESCO Finland
Radical radiotherapy
86.4
30.0
33
*
K83.1
ICD-10 Finland
Obstruction of bile duct
25.7
28.2
39
16
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
28.0
283
1450
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.1
27.4
179
702
WX402
NOMESCO Finland
General anaesthesia
3.4
26.9
146
499
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
35.6
26.7
34
10
B01AB05
ATC
enoxaparin; parenteral
2.5
26.5
269
1371
TPH07
NOMESCO Finland
Cathetrisation of artery
3.8
26.5
121
360
L02BG04
ATC
letrozole; oral
38.3
26.3
33
9
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
24.3
26.3
37
16
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
26.2
25
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.4
25.8
99
250
L03AA13
ATC
pegfilgrastim; parenteral
258.4
24.8
25
*
Z71.8
ICD-10 Finland
Other specified counselling
2.6
24.3
217
1021
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.5
24.2
237
1171
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.1
24.1
79
169
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
24.1
23
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
24.1
23
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
24.1
23
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
24.1
213
994
UJF32
NOMESCO Finland
Coloscopy
2.5
23.5
239
1203
N02BE01
ATC
paracetamol; systemic, rectal
3.2
23.5
645
5321
Z51.5
ICD-10 Finland
Palliative care
9.0
23.4
50
59
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
37.7
23.1
29
8
HAC20
NOMESCO Finland
Total mastectomy
+∞
23.0
22
*
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
10.4
22.8
45
46
D13.7
ICD-10 Finland
Benign neoplasm: Endocrine pancreas
123.9
22.7
24
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
46.6
22.5
27
6
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
22.5
133
479
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
22.0
21
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
22.0
21
*
JN4AD
NOMESCO Finland
Body CT examination
5.9
21.8
63
116
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
118.6
21.7
23
*
A02BC02
ATC
pantoprazole; systemic
2.2
21.6
502
3677
R50.9
ICD-10 Finland
Fever, unspecified
3.2
21.6
123
430
N02AA05
ATC
oxycodone; systemic
3.2
21.4
127
456
R4190
NOMESCO Finland
Nutritional therapy
9.5
21.4
44
49
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
20.9
20
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
79.1
20.8
23
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
113.2
20.7
22
*
K83.0
ICD-10 Finland
Cholangitis
11.7
20.2
37
33
R4110
NOMESCO Finland
Physiotherapy
2.3
20.0
220
1138
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
19.9
288
1691
Z3231
NOMESCO Finland
Registered nurse
2.3
19.9
227
1195
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
75.6
19.8
22
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
19.7
160
703
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
13.1
19.5
34
27
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
12.2
18.9
34
29
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
30.9
18.4
24
8
RD211
NOMESCO Finland
NA
4.9
18.4
62
137
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
4.0
17.9
75
205
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
17.8
17
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
17.8
17
*
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
+∞
17.8
17
*
A04AD12
ATC
aprepitant; systemic
+∞
17.8
17
*
A04AA01
ATC
ondansetron; systemic, rectal
7.2
16.9
41
60
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
14.5
16.9
28
20
A04AA55
ATC
palonosetron, combinations; systemic
+∞
16.7
16
*
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
13.8
16.6
28
21
J01MA12
ATC
levofloxacin; systemic
2.4
16.4
158
754
JAH01
NOMESCO Finland
Laparoscopy
5.0
16.3
53
113
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
13.2
16.3
28
22
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.9
16.1
53
114
K86.3
ICD-10 Finland
Pseudocyst of pancreas
21.5
16.1
23
11
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
10.7
15.8
30
29
K86.1
ICD-10 Finland
Other chronic pancreatitis
16.1
15.8
25
16
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
13.3
15.8
27
21
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
+∞
15.7
15
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
15.7
15
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
15.7
15
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
15.7
15
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
15.7
15
*
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
15.7
15
*
K86.8
ICD-10 Finland
Other specified diseases of pancreas
24.0
15.2
21
9
K85.8
ICD-10 Finland
Other acute pancreatitis
20.6
15.2
22
11
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
14.3
15.1
25
18
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
15.0
118
503
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
+∞
14.6
14
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
81.7
14.6
16
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
14.3
171
896
HAB40
NOMESCO Finland
Wedge excision of mammary gland
22.8
14.3
20
9
L02AE02
ATC
leuprorelin; implant, parenteral
18.0
13.9
21
12
N02AX02
ATC
tramadol; systemic, rectal
1.9
13.8
324
2201
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
13.8
135
644
Y77
ICPC
Malignant neoplasm prostate
76.6
13.6
15
*
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
+∞
13.6
13
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
13.6
13
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
13.6
13
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
13.6
13
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
13.6
13
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.8
13.5
93
365
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.2
13.5
52
132
L03AA02
ATC
filgrastim; parenteral
142.5
13.5
14
*
ZXE00
NOMESCO Finland
One hour or less
1.8
12.8
283
1874
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
71.1
12.6
14
*
L02BB03
ATC
bicalutamide; oral
+∞
12.5
12
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
12.5
279
1847
J01MA02
ATC
ciprofloxacin; systemic
1.8
12.5
293
1972
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
12.2
93
388
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
13.7
12.0
20
15
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
47.5
11.9
14
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
66.0
11.6
13
*
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.4
11.6
102
460
D76
ICPC
Malignant neoplasm pancreas
+∞
11.5
11
*
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
+∞
11.5
11
*
8000/3-C25.9
ICD-O-3
Neoplasm, malignant of pancreas, NOS
+∞
11.5
11
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
11.5
11
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.7
11.3
28
43
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
13.0
11.2
19
15
WW500
NOMESCO Finland
Blood transfusion
5.5
11.1
32
60
J01DB01
ATC
cefalexin; oral
1.9
11.1
566
4786
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
11.0
246
1614
R93.3
ICD-10 Finland
Abnormal findings on diagnostic imaging of other parts of digestive tract
44.0
10.9
13
*
XKD00
NOMESCO Finland
Uroflowmetry
2.2
10.9
116
572
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
13.1
10.7
18
14
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.8
10.5
34
73
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
14.5
10.5
17
12
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
10.4
10
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
10.4
10
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
10.4
10
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
10.4
10
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
10.4
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
10.4
10
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
10.4
10
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
10.4
73
291
Z00.0
ICD-10 Finland
General medical examination
2.0
10.3
143
788
JAH00
NOMESCO Finland
Laparotomy
4.9
10.2
32
67
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
10.0
66
252
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
6.9
10.0
24
36
Z3226
NOMESCO Finland
Physiotherapist
2.0
9.9
137
754
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.7
9.9
43
123
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
7.5
9.7
22
30
K85
ICD-10 Finland
Acute pancreatitis
5.9
9.7
26
45
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
55.7
9.7
11
*
S18
ICPC
Laceration/cut
1.7
9.6
300
2155
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.4
9.6
45
137
L57.0
ICD-10 Finland
Actinic keratosis
2.6
9.6
73
303
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
9.3
9.6
19
21
A05AA02
ATC
ursodeoxycholic acid; oral
7.3
9.6
22
31
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.8
9.5
202
1295
Z51.0
ICD-10 Finland
Radiotherapy session
101.2
9.4
10
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
17.8
9.4
14
8
UJK12
NOMESCO Finland
Peroral cholangioscopy
30.4
9.4
12
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
9.4
9
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
9.4
9
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
9.4
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.4
9
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
9.4
9
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.4
9.3
81
363
R53
ICD-10 Finland
Malaise and fatigue
1.9
9.3
153
895
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
9.3
198
1268
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.7
9.2
64
252
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
9.1
168
1025
ZX112
NOMESCO Finland
Subcutaneous
15.8
9.1
14
9
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
9.0
156
931
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
18.9
9.0
13
7
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
24.3
8.9
12
5
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
24.3
8.9
12
5
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.6
8.9
66
272
A02BC05
ATC
esomeprazole; systemic
1.6
8.8
300
2188
HAB99
NOMESCO Finland
Other partial excision of mammary gland
10.9
8.8
16
15
TKE00
NOMESCO Finland
Needle biopsy of prostate
4.9
8.6
27
57
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
20.3
8.5
12
6
JLB28
NOMESCO Finland
Endoscopic internal drainage of pancreatic duct
20.3
8.5
12
6
T90
ICPC
Diabetes non-insulin dependent
1.7
8.5
189
1223
ZXA00
NOMESCO Finland
Right side
1.7
8.4
200
1319
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.6
8.4
36
103
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
+∞
8.3
8
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
8.3
8
*
8500/3-C25.0
ICD-O-3
Infiltrating duct carcinoma, NOS, of head of pancreas
+∞
8.3
8
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
8.3
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.3
8
*
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
+∞
8.3
8
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
8.3
8
*
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
8.3
217
1469
SPAT1131
SPAT
Colonoscopy
3.5
8.3
37
109
ZXA05
NOMESCO Finland
Left side
1.7
8.3
186
1205
KCD02
NOMESCO Finland
Transurethral resection of bladder
14.7
8.2
13
9
XQ848
NOMESCO Finland
Dermatological photography
5.2
8.2
24
47
UKC02
NOMESCO Finland
Cystoscopy
2.0
8.2
115
634
ZXC50
NOMESCO Finland
Cryotherapy
4.6
8.1
27
61
ZZR00
NOMESCO Finland
Flap of skin
11.9
8.1
14
12
L02BA01
ATC
tamoxifen; oral
33.7
8.1
10
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.2
8.1
29
71
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
22.3
8.0
11
5
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.7
7.8
53
206
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
7.8
304
2276
-1
NOMESCO Finland
NA
1.7
7.8
209
1422
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.0
7.8
108
593
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
3.7
7.7
32
89
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
15.2
7.7
12
8
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
45.4
7.7
9
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.7
7.7
21
38
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
9.0
7.6
15
17
Z2221
NOMESCO Finland
Medical doctor
1.7
7.6
185
1223
SPAT1262
SPAT
Handing over of treatment supplies
1.8
7.4
146
904
JL5AM
NOMESCO Finland
Bile and pancreas ducts simple MRI examination with 3 Tesla magnet
80.8
7.4
8
*
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.1
7.4
86
441
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
7.3
7
*
X76
ICPC
Malignant neoplasm breast female
+∞
7.3
7
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
7.3
7
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
7.3
7
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
7.3
7
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
7.3
7
*
XX1AD
NOMESCO Finland
Other CT-examination
+∞
7.3
7
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
JL2AT
NOMESCO Finland
Cytology of pancreas with ultrasound guidance
+∞
7.3
7
*
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
+∞
7.3
7
*
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
+∞
7.3
7
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.3
7
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
7.3
7
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
7.3
7
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
7.3
70
331
Z25.1
ICD-10 Finland
Need for immunization against influenza
2.6
7.2
51
207
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.3
7.2
25
60
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
30.3
7.2
9
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.8
7.2
45
167
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
5.4
7.1
20
38
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
10.2
7.0
13
13
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.7
7.0
45
172
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.4
7.0
58
256
ZYC01
NOMESCO Finland
Remote contact by phone
3.0
6.9
37
126
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.6
6.9
48
191
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
13.9
6.9
11
8
WX110
NOMESCO Finland
Local anesthesy
1.5
6.9
424
3496
UJF92
NOMESCO Finland
Capsular endoscopy
4.2
6.9
24
58
ZXC96
NOMESCO Finland
Robot assisted procedure
11.1
6.8
12
11
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
6.8
167
1104
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.2
6.6
63
296
HA1AA
NOMESCO Finland
X-ray mammography
3.3
6.6
31
97
ZXC15
NOMESCO Finland
Use of photodynamic technique
8.8
6.6
13
15
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.7
6.6
43
167
XW000
NOMESCO Finland
Bone marrow biopsy
3.4
6.5
29
87
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
70.4
6.4
7
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
70.4
6.4
7
*
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
7.5
6.4
14
19
NK6AN
NOMESCO Finland
Total body bone isotope imaging
14.4
6.4
10
7
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
4.5
6.4
21
48
N03AX16
ATC
pregabalin; oral
1.6
6.3
164
1096
AN2
HP
Balloon angioplasty, including several vessels
3.2
6.3
30
95
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.0
6.3
80
425
D02
ICPC
Abdominal pain epigastric
2.6
6.3
44
177
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
6.3
6
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
6.3
6
*
C25
ICD-10 Finland
Malignant neoplasm of pancreas
+∞
6.3
6
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
+∞
6.3
6
*
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
+∞
6.3
6
*
197
Kela drug reimbursment
Sunitinib
+∞
6.3
6
*
JDE00
NOMESCO Finland
Gastrojejunostomy
+∞
6.3
6
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
6.3
6
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
6.3
6
*
JLD12
NOMESCO Finland
Endoscopic drainage of pancreatic pseudocyst
+∞
6.3
6
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
6.3
6
*
158
Kela drug reimbursment
Everolimus
+∞
6.3
6
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.3
6.2
54
244
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.2
6.2
22
54
TPX15
NOMESCO Finland
Removal of vascular injection port
26.9
6.2
8
*
H01CB02
ATC
octreotide; parenteral
26.9
6.2
8
*
ZXD05
NOMESCO Finland
Urgent procedure
1.6
6.2
199
1404
A10AE04
ATC
insulin glargine; parenteral
2.0
6.2
76
400
C07AB07
ATC
bisoprolol; oral
1.5
6.2
363
2934
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
6.2
121
748
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.7
6.1
25
70
R52.0
ICD-10 Finland
Acute pain
3.7
6.1
25
70
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.1
6.1
22
55
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
3.9
6.1
23
60
K59.09
ICD-10 Finland
Constipation, unspecified
2.3
6.0
54
245
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
4.0
6.0
22
56
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.8
6.0
103
608
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
305
128
36.44
307.65
4.5
2.0
u/ml
76.9
105.4
0.16
273
102
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
433
380
22.01
307.65
3.6
1.5
ug/l
2.8
3.6
0.51
363
287
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
341
71
79.11
307.65
3.3
1.8
u/ml
41.1
69.4
0.43
315
65
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
317
531
8.89
196.72
2.9
1.8
g/l
0.2
0.2
9.83
309
476
(3000570) Elastase.pancreatic [Mass/mass] in Stool
172
182
11.57
151.20
1.6
1.4
ug/g
218.6
309.3
4.71
127
105
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
305
658
6.64
144.55
4.1
2.2
umol/l
6.3
7.4
0.77
275
565
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
570
2223
5.67
134.63
4.1
2.2
u/l
64.0
57.3
0.81
552
2023
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
714
3401
7.59
132.02
10.5
3.7
umol/l
11.0
11.8
1.06
700
3172
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
246
551
5.86
109.28
4.9
1.9
u/l
244.6
35.3
1.35
222
454
(4035726)
147
193
8.99
108.56
1.4
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
597
3022
4.22
85.72
8.2
3.6
g/l
34.4
35.5
5.60
584
2783
(3032080) INR in Blood by Coagulation assay
582
2986
3.96
79.72
10.5
10.4
inr
1.2
1.3
3.59
248
844
(3021589) Normoblasts [#/volume] in Blood
559
3013
3.46
66.06
16.6
8.7
e9/l
0.0
0.0
0.50
489
2459
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
792
5421
7.08
65.07
13.9
5.3
u/l
86.0
75.4
6.30
779
4980
(3002256) Pathology report gross observation
179
508
4.19
56.86
1.5
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
667
4244
3.58
55.38
6.8
4.3
mmol/l
7.0
6.8
1.20
652
3969
(40768804) Tissue Pathology biopsy report
444
2260
3.00
54.54
2.8
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
43
28
16.12
49.72
1.7
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
411
2084
2.87
49.59
4.4
2.6
u/l
34.1
32.7
0.28
400
1980
(3026782) Osmolality of Urine
311
1359
3.02
49.42
3.8
2.6
mosm/kgh2o
513.6
542.6
1.59
286
1139
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
70
96
7.85
48.97
1.2
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
347
1633
2.89
47.83
6.7
3.4
%
89.0
87.0
0.66
341
1592
(3002582) Erythrocytes [#/volume] in Urine
408
2093
2.81
47.67
4.3
3.1
e6/l
58.2
91.8
0.39
344
1612
(3013650) Neutrophils [#/volume] in Blood by Automated count
595
3760
2.91
45.48
11.9
6.3
e9/l
4.5
4.3
1.04
546
3250
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
173
561
3.61
44.68
5.1
2.8
mmol/l
1.2
1.2
0.33
165
464
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
43
35
12.88
43.83
2.6
1.3
ug/l
12.3
15.4
0.86
43
35
(3017181) Myelocytes/100 leukocytes in Blood
166
540
3.57
42.54
4.8
3.8
%
1.0
0.8
0.38
35
113
(3012095) Magnesium [Moles/volume] in Serum or Plasma
245
1008
3.00
42.48
3.5
2.4
mmol/l
0.8
0.8
1.93
232
921
(3030467) Casts [#/volume] in Urine by Automated count
375
1932
2.67
42.18
4.1
3.0
e6/l
0.5
0.4
0.29
313
1470
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
508
3041
2.65
41.81
5.8
3.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
160
514
3.60
41.75
4.8
3.9
%
0.2
0.1
0.95
34
98
(3023368) Bacteria identified in Blood by Culture
360
1833
2.66
41.27
6.7
4.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
155
494
3.61
40.88
5.0
4.0
%
0.0
1.0
0.52
30
92
(3018095) Leukocytes [#/volume] in Urine
437
2476
2.56
39.70
5.4
3.5
e6/l
94.5
101.6
0.09
359
1747
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
562
3593
2.64
39.41
8.8
5.4
mmol/l
1.2
1.2
0.32
468
3039
(3018418) pH of Serum or Plasma
386
2077
2.56
38.93
5.7
3.2
ph
7.4
7.4
1.47
142
355
(36304419) Bacteria [Presence] in Urine
356
1867
2.55
37.61
4.1
3.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
310
1558
2.55
35.43
8.7
4.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
300
1485
2.57
35.39
3.4
2.4
e6/l
5.5
5.7
0.11
262
1297
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
515
3260
2.45
35.27
7.9
5.0
mmol/l
1.2
1.2
1.15
498
2875
(3002179) Metamyelocytes/100 leukocytes in Blood
147
496
3.37
35.19
4.7
3.8
%
0.6
0.5
0.15
28
87
(3018677) aPTT in Platelet poor plasma by Coagulation assay
245
1106
2.70
34.81
2.5
1.8
s
30.2
29.9
0.37
240
1064
(40768797) Stomach Pathology biopsy report
233
1026
2.75
34.76
1.6
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
213
903
2.81
34.12
6.5
4.4
mmol/l
1.0
1.0
0.31
206
815
(3024980) IgG subclass 4 [Mass/volume] in Serum
53
95
5.88
28.65
1.8
2.1
g/l
0.5
1.1
2.41
33
74
(3044640) Blood type and Crossmatch panel - Blood
346
1981
2.25
28.05
3.3
2.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
129
464
3.10
27.45
3.2
2.2
g/l
10.5
10.8
0.45
112
424
(3002385) Erythrocyte distribution width [Ratio]
728
5707
2.83
27.27
32.1
15.7
%
14.0
13.7
7.37
722
5556
(3022096) Basophils/100 leukocytes in Blood
467
3053
2.16
26.70
7.1
5.7
%
0.7
0.7
0.79
450
2813
(3006315) Basophils [#/volume] in Blood
505
3410
2.17
26.48
7.1
5.5
e9/l
0.0
0.0
0.79
446
2926
(3019069) Monocytes/100 leukocytes in Blood
479
3169
2.16
26.48
7.1
5.9
%
8.8
8.7
0.34
460
2927
(3001604) Monocytes [#/volume] in Blood
503
3394
2.17
26.39
7.1
5.5
e9/l
0.6
0.6
1.86
445
2903
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
225
1097
2.43
26.29
3.4
2.8
e6/l
2.2
2.6
0.29
136
590
(3029937) Albumin [Presence] in Urine by Test strip
334
1927
2.20
26.16
5.1
4.1
estimate
0.0
0.0
0.50
182
584
(3006504) Eosinophils/100 leukocytes in Blood
475
3157
2.13
25.64
7.1
5.7
%
2.7
3.0
1.81
457
2902
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
196
911
2.49
25.33
3.7
2.4
%
22.7
23.4
0.23
180
770
(3044889) 12 lead EKG panel
684
5272
2.47
25.30
5.1
4.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
507
3468
2.13
25.20
7.2
5.5
e9/l
1.9
1.9
0.22
454
3022
(3004789) Transferrin [Mass/volume] in Serum or Plasma
207
989
2.44
25.18
3.5
2.3
g/l
2.3
2.3
0.09
195
916
(40760892) CBC W Ordered Manual Differential panel - Blood
267
1430
2.26
24.90
5.3
4.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
480
3226
2.11
24.87
7.2
5.8
%
26.1
27.3
1.48
458
2968
(3031040) Bacteria [#/volume] in Urine by Automated count
629
4713
2.26
24.28
5.8
4.6
e6/l
44.0
2600.9
—
6
69
(3022145) Colonoscopy Study observation
161
694
2.63
24.27
1.4
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
510
3528
2.10
24.20
7.4
5.6
e9/l
0.2
0.2
0.04
458
3068
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
68
180
4.02
23.09
2.3
1.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
60
147
4.31
22.58
4.2
4.6
mmol/l
2.9
2.8
0.05
47
102
(3018010) Neutrophils/100 leukocytes in Blood
467
3194
2.02
22.06
6.9
5.6
%
58.8
57.7
1.10
448
2957
(3022948) Iron [Moles/volume] in Serum or Plasma
212
1094
2.25
21.19
3.5
2.3
umol/l
12.4
13.3
0.86
200
996
(3041096) Erythrocytes [Presence] in Urine by Automated
305
1815
2.06
21.06
4.4
3.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
282
1644
2.07
20.49
1.4
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
495
3516
1.97
20.31
4.6
3.8
estimate
0.0
0.0
0.00
183
603
(3021601) Nitrite [Presence] in Urine by Test strip
497
3536
1.97
20.28
5.6
5.1
estimate
0.0
0.0
0.00
187
596
(3042936) Bacteria identified in Isolate by Culture
195
991
2.25
20.12
2.8
2.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
363
2327
1.97
20.09
4.3
2.1
mmol/l
2.4
2.4
0.05
343
1916
(3009261) Glucose [Presence] in Urine by Test strip
499
3579
1.94
19.61
4.6
3.8
estimate
0.0
0.0
0.00
185
586
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
156
738
2.36
18.95
4.6
3.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
25
32
8.02
18.36
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
29
45
6.64
18.01
1.2
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
239
1374
2.03
17.63
4.0
2.2
mmol/l
2.5
2.4
3.12
217
1193
(3020779) Urea [Moles/volume] in Serum or Plasma
131
593
2.43
17.49
8.5
5.7
mmol/l
9.8
10.2
0.31
123
560
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
433
3037
1.86
17.46
2.8
2.3
nmol/l
79.4
79.4
0.01
411
2634
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
21
5
42.94
17.34
2.6
1.0
u/ml
14.7
14.8
—
21
5
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
806
7083
3.32
16.96
27.7
13.0
mg/l
29.2
23.6
4.37
715
5488
(42870588) Differential panel, method unspecified - Blood
347
2289
1.87
16.84
6.9
5.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
48
124
4.04
16.83
1.8
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
41
96
4.44
16.34
1.6
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
43
105
4.26
16.24
1.7
1.2
nmol/l
0.6
0.6
0.85
38
98
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
141
687
2.26
15.82
4.3
2.9
u/l
231.2
241.2
0.38
134
642
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
61
194
3.31
15.77
2.8
2.8
u/ml
0.2
0.4
7.12
38
116
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
557
4308
1.84
15.58
4.6
3.0
u/l
73.7
47.3
3.44
532
3947
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
389
2709
1.80
15.44
4.7
4.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
414
2950
1.78
15.09
4.3
3.9
ng/l
40.0
65.2
0.55
309
2154
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
38
90
4.37
14.93
1.7
1.2
nmol/l
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
339
2308
1.78
14.22
4.0
3.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
209
1242
1.90
13.54
1.9
1.3
g/l
2.6
2.7
0.39
153
706
(40768793) Breast Pathology biopsy report
27
52
5.33
13.50
1.3
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
117
565
2.24
13.32
4.7
3.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
770
6772
2.35
13.23
26.8
12.0
ml/min/173m2
75.7
76.1
0.25
725
5426
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
50
157
3.32
13.20
3.3
2.3
g/l
3.9
3.6
0.54
50
149
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
104
482
2.32
13.04
1.7
1.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
28
58
4.96
12.92
1.3
1.2
u/l
62.4
47.3
0.96
23
38
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
36
93
4.00
12.64
6.2
5.5
iu/ml
256.7
150.1
—
6
10
(3001122) Ferritin [Mass/volume] in Serum or Plasma
400
2929
1.69
12.42
4.3
2.7
ug/l
132.5
130.3
0.07
383
2657
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
236
1492
1.80
12.41
2.0
1.6
mg/l
1.5
1.3
0.48
184
1161
(3020891) Body temperature
77
318
2.56
12.41
6.1
4.4
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
16
19
8.56
12.40
1.5
1.1
umol/l
29.3
29.7
0.05
16
19
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
280
1862
1.75
12.37
2.8
2.2
mg/l
3.4
2.9
1.60
253
1566
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
17
22
7.86
12.32
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
44
135
3.38
12.05
4.0
3.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
193
1160
1.86
11.91
2.0
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
148
817
1.98
11.79
2.0
1.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
117
593
2.13
11.76
3.0
1.5
g/l
66.4
67.2
0.57
111
528
(4062490)
28
63
4.56
11.73
1.4
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
112
559
2.15
11.71
10.2
6.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
77
327
2.49
11.70
1.5
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
198
1211
1.83
11.51
3.2
2.6
e6/l
1.3
1.2
0.04
107
702
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
17
24
7.21
11.45
1.1
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
603
4977
1.71
11.41
5.4
4.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
238
1547
1.75
11.22
3.3
2.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
146
818
1.95
11.11
2.0
1.7
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
115
598
2.07
10.78
7.2
5.7
mmol/l
1.3
1.4
0.93
106
578
(3003396) Base excess in Arterial blood by calculation
146
826
1.93
10.77
8.0
6.5
mmol/l
0.8
1.3
1.29
119
633
(3013707) Erythrocyte sedimentation rate by Westergren method
646
5468
1.74
10.77
5.5
4.3
mm/h
15.2
12.6
3.43
620
5012
(3004588) Protein electrophoresis panel - Serum or Plasma
105
529
2.12
10.69
2.4
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
115
606
2.04
10.38
2.7
2.3
ml/min/173m2
68.7
64.2
0.59
57
235
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
116
614
2.03
10.35
1.7
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
61
247
2.58
10.24
2.7
1.4
g/l
0.9
0.3
1.35
53
209
(3017143) Hepatitis C virus Ab [Presence] in Serum
107
553
2.07
10.18
1.7
1.4
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
26
62
4.29
10.15
1.5
1.6
g/l
0.3
0.4
—
10
46
(3027135) IgG subclass 1 [Mass/volume] in Serum
26
62
4.29
10.15
1.5
1.6
g/l
6.4
7.1
—
10
46
(3028192) IgG subclass 2 [Mass/volume] in Serum
26
62
4.29
10.15
1.5
1.6
g/l
2.7
2.7
—
10
46
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
55
214
2.68
9.99
2.9
1.4
g/l
0.0
0.0
0.07
49
196
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
40
131
3.15
9.90
3.3
3.3
%
57.0
59.7
0.79
40
131
(3035637) Corticotropin [Mass/volume] in Plasma
23
51
4.61
9.82
1.8
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
39
127
3.17
9.74
2.9
3.1
e9/l
4.5
4.4
0.03
39
127
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
278
2.45
9.74
2.5
1.4
g/l
2.9
3.1
0.52
43
213
(3026493) Urate [Moles/volume] in Serum or Plasma
275
1927
1.63
9.51
3.7
2.4
umol/l
2081.9
6829.7
1.59
252
1635
(40768795) Lymph node Pathology biopsy report
13
17
7.75
9.29
1.5
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
39
131
3.07
9.26
1.4
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
169
1047
1.76
9.23
24.3
28.0
inr
1.6
1.4
0.78
17
147
(3003327) Ova and parasites identified in Stool by Light microscopy
49
188
2.70
9.16
1.3
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
34
106
3.30
9.12
1.3
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
348
2603
1.57
9.03
3.4
3.2
mmol/l
6.5
7.2
2.36
305
2187
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
52
208
2.60
8.96
2.9
1.4
ratio
1.6
1.2
1.85
14
18
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
37
123
3.10
8.95
4.8
2.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
43
1029
0.39
8.94
4.6
5.1
%
34.8
33.1
0.41
35
668
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
14
21
6.76
8.92
2.0
2.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
41
145
2.92
8.91
1.4
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
20
43
4.74
8.86
3.0
2.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
126
730
1.85
8.56
1.8
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
29
85
3.50
8.56
1.6
1.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
6
20.25
8.48
1.1
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
298
2.28
8.35
2.5
1.4
g/l
3.7
3.8
0.33
43
210
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
298
2.28
8.35
2.5
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
298
2.28
8.35
2.5
1.4
g/l
7.4
7.5
0.18
44
219
(3020682) Albumin/Creatinine [Ratio] in Urine
353
2685
1.54
8.31
4.3
4.0
mg/mmol
6.6
8.0
0.51
241
1662
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
52
216
2.50
8.31
3.0
1.4
mg/l
29.1
36.8
1.02
44
165
(3034860) Kappa light chains.free [Mass/volume] in Serum
52
216
2.50
8.31
3.0
1.4
mg/l
36.5
46.6
1.15
44
165
(3030981) Hyaline casts [#/volume] in Urine by Automated count
74
359
2.16
8.29
3.5
2.4
e6/l
0.1
0.2
2.78
74
348
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
28
82
3.50
8.28
1.5
1.3
u/ml
91.2
111.2
—
5
15
(3023103) Potassium [Moles/volume] in Serum or Plasma
814
7580
2.47
8.13
31.0
16.0
mmol/l
4.0
4.0
0.68
809
7357
(3045142) Bone marrow Pathology biopsy report
20
47
4.33
7.97
1.5
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
29
91
3.26
7.72
2.4
1.3
mu/l
43.6
50.1
0.10
23
80
(3025941) Bacteria identified in Stool by Culture
71
349
2.13
7.70
1.4
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
12
18
6.75
7.62
2.2
2.7
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
24
67
3.66
7.62
3.8
3.5
mg/l
30.0
15.2
0.66
17
54
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
26
78
3.41
7.43
1.3
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
29
94
3.16
7.34
1.4
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
333
2554
1.50
7.28
3.4
3.2
mg/l
411.9
182.4
0.41
231
1576
(3047189) Immunofixation for 24 hour Urine
11
16
6.95
7.16
3.0
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
38
146
2.68
7.13
3.1
2.6
%
15.9
16.4
0.19
19
66
(3037522) Nuclear Ab [Titer] in Serum
146
930
1.69
7.11
1.4
1.3
titre
633.1
631.4
0.00
29
229
(40760888) Immunoglobulin light chains.free panel - Serum
40
158
2.61
7.11
2.9
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
27
86
3.21
7.04
1.2
1.2
u/ml
322.7
285.2
0.19
21
45
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
20
52
3.91
7.01
1.5
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
794
7387
2.02
6.85
25.7
12.9
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
19
49
3.94
6.74
1.0
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
28
95
3.01
6.59
1.1
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
210
1489
1.54
6.54
4.1
4.0
ng/l
245.3
425.4
0.58
168
1232
(3027945) Reticulocytes/100 erythrocytes in Blood
136
869
1.67
6.52
2.3
2.0
%
1.8
1.8
0.16
131
763
(3022689) Creatine [Moles/volume] in Urine
13
25
5.26
6.50
2.0
1.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
51
237
2.22
6.38
2.7
1.4
g/l
37.9
37.6
0.17
43
194
(3049717) Cytology report of Urine Cyto stain
51
238
2.22
6.32
3.5
1.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
29
103
2.88
6.31
2.0
1.4
—
—
—
0
0
(4281824)
15
35
4.34
6.04
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
202
1445
1.52
5.98
1.3
1.2
u/ml
1.0
2.0
1.44
83
388
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
18
49
3.73
5.94
1.0
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
86
501
1.80
5.72
6.5
4.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
75
420
1.86
5.67
1.6
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
317
2504
1.42
5.58
2.8
3.0
ng/l
1323.9
1304.4
0.03
290
2128
(3003181) Sodium [Moles/volume] in Urine
34
141
2.47
5.52
1.3
1.4
mmol/l
54.7
63.5
0.73
27
117
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
66
359
1.91
5.45
3.0
2.9
pmol/l
4.5
4.5
0.11
60
310
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
753
6979
1.65
5.43
7.9
6.5
mmol/mol
42.1
40.6
4.11
736
6412
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
43
203
2.18
5.22
2.9
1.4
g/l
0.0
0.0
0.00
38
186
(21494890) Protein electrophoresis panel - 24 hour Urine
19
59
3.27
5.19
2.7
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
115
751
1.61
5.04
2.4
2.1
ug/g
171.1
158.4
0.16
96
591
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
31
129
2.46
5.02
1.5
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
64
355
1.87
5.00
10.2
9.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
26
100
2.65
4.93
1.2
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
32
4.11
4.91
1.4
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
77
455
1.76
4.90
1.7
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
59
321
1.90
4.89
12.5
3.4
mmol/l
23.9
24.5
0.80
51
284
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
304
2427
1.39
4.89
2.3
2.2
u/l
133.6
236.2
2.30
294
2261
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
278
1.97
4.89
2.6
1.4
g/l
9.7
10.6
0.95
43
230
(3017817) Protein [Mass] in Urine collected for unspecified duration
20
67
3.03
4.85
1.9
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
12
28
4.33
4.83
4.2
4.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
28
4.33
4.83
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
623
5595
1.42
4.82
4.4
3.9
pmol/l
15.1
15.0
0.49
587
5037
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
31
132
2.40
4.79
1.7
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
102
656
1.63
4.76
2.6
2.3
e9/l
69.3
69.5
0.02
77
512
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
36
166
2.22
4.65
1.3
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
45
228
2.03
4.58
2.3
3.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
81
2.76
4.54
2.0
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
94
2.60
4.41
1.3
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
24
94
2.60
4.41
2.9
2.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
30
131
2.34
4.40
1.2
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
17
55
3.13
4.38
1.2
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
31
138
2.29
4.36
1.7
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
229
1773
1.40
4.33
1.9
1.8
pmol/l
451.9
31010885.7
1.99
193
1435
(3026361) Erythrocytes [#/volume] in Blood
822
7883
2.05
4.31
39.6
19.5
e12/l
4.3
4.5
11.30
813
7608
(3010813) Leukocytes [#/volume] in Blood
822
7884
2.04
4.29
39.6
19.5
e9/l
7.1
6.7
5.96
813
7613
(3002032) Base excess in Venous blood by calculation
104
690
1.58
4.27
6.2
3.0
mmol/l
1.4
2.2
1.12
89
553
(3000963) Hemoglobin [Mass/volume] in Blood
822
7886
2.04
4.26
39.9
19.6
g/l
129.6
135.2
22.80
817
7737
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
24
96
2.54
4.24
1.9
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
61
352
1.79
4.23
9.4
7.9
mmol/l
24.0
24.7
1.16
56
321
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
18
62
2.94
4.19
2.2
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
434
3728
1.33
4.16
2.7
2.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
821
7881
1.99
4.12
39.7
19.5
e9/l
253.9
246.6
2.16
814
7634
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
32
3.79
4.09
1.3
1.6
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
13
37
3.55
4.06
1.6
1.5
nmol/l
0.9
1.1
0.63
13
27
(3004451) EKG impression Narrative
14
42
3.37
4.05
1.4
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
30
138
2.22
3.93
1.4
1.2
iu/l
37.9
28.7
0.61
23
123
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
93
615
1.57
3.88
5.9
3.5
ng/l
83.9
88.0
0.19
78
530
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
49
3.10
3.82
1.4
1.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
55
318
1.78
3.81
1.9
1.6
g/l
1.4
1.5
0.39
48
274
(3045414) Leukocytes [Presence] in Urine
55
319
1.77
3.77
2.2
1.9
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
53
305
1.79
3.74
1.7
2.0
u/l
40.0
39.6
0.06
48
260
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
28
129
2.21
3.67
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
28
129
2.21
3.67
1.4
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
388
3320
1.31
3.66
2.4
2.0
pmol/l
89.2
95.5
2.37
240
1637
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
14
46
3.08
3.54
1.8
1.3
titre
98.0
230.0
—
5
9
(3023183) Ammonium ion [Moles/volume] in Plasma
29
138
2.14
3.53
1.4
2.6
umol/l
34.2
34.1
0.01
21
118
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
70
1066
0.63
3.51
15.6
6.8
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
8
13
6.20
3.50
1.3
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
39
208
1.92
3.50
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
92
0.00
3.48
0.0
1.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
46
260
1.81
3.45
2.3
1.7
titre
116.7
146.2
—
6
13
(3021960) Folate [Moles/volume] in Serum or Plasma
242
1952
1.33
3.44
1.7
1.5
nmol/l
21.9
20.8
0.56
226
1618
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
30
147
2.08
3.40
1.6
1.8
nmol/l
52.5
43.8
0.28
30
137
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
19
76
2.53
3.39
1.1
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
112
795
1.47
3.38
1.9
1.8
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
18
5.04
3.37
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
108
2.26
3.34
1.7
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
717
6727
1.40
3.33
5.3
4.8
mu/l
1.9
2.2
0.74
682
6080
(3044242) Glucose [Moles/volume] in Arterial blood
14
48
2.95
3.31
3.3
2.1
—
—
—
0
0
(3015736) pH of Urine
329
2783
1.30
3.29
3.9
3.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
22
96
2.33
3.29
1.3
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
14
49
2.89
3.20
1.1
1.2
mmol/l
9.8
11.6
—
9
15
(40768446) Kidney Pathology biopsy report
8
15
5.37
3.19
1.7
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
23
104
2.24
3.18
1.2
1.1
iu/ml
28.2
174.5
—
5
19
(3043410) Blood group antigens tested for on Red Blood Cells
8
16
5.04
3.05
3.5
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
5
10.05
2.98
3.8
6.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
40
3.03
2.98
1.0
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
112
817
1.43
2.94
1.9
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
22
4.12
2.88
2.6
2.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
38
215
1.80
2.88
1.2
1.6
g/l
0.2
0.2
0.03
38
207
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
9
6.70
2.87
6.5
7.2
mmol/l
4.9
5.9
—
6
9
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
41
2.95
2.86
1.3
1.4
—
—
—
0
0
(3000492) Spirometry study
85
591
1.49
2.86
1.6
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
19
393
0.47
2.78
1.2
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
42
2.88
2.76
2.1
2.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
91
647
1.45
2.75
1.6
1.7
%
1.7
1.5
0.65
74
535
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
253
2111
1.28
2.72
1.7
1.7
mmol/l
1.4
1.4
0.74
218
1744
(3022806) Fractional oxyhemoglobin in Capillary blood
21
98
2.17
2.72
1.7
2.1
%
91.3
89.8
1.01
21
98
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
10
6.03
2.70
1.3
2.8
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
9
24
3.78
2.67
2.6
2.1
nmol/l
1.4
10.1
—
9
18
(3014765) Yersinia sp identified in Stool by Organism specific culture
37
213
1.77
2.67
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
37
215
1.75
2.60
1.3
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
27
142
1.93
2.58
1.2
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
12
44
2.75
2.55
1.6
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
7
7.18
2.55
2.2
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
33
3.05
2.53
1.1
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
88
2.19
2.52
1.9
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
14
57
2.48
2.46
1.0
1.0
mg/l
292.9
279.6
0.27
14
52
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
36
212
1.73
2.43
1.3
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
174
1403
1.30
2.42
3.4
2.8
ug/l
0.8
0.7
0.16
124
956
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
34
2.96
2.42
1.3
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
34
2.96
2.42
1.3
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
37
220
1.71
2.41
1.3
1.5
g/l
1.1
1.2
0.20
37
209
(3013139) Helicobacter pylori Ag [Presence] in Stool
69
482
1.47
2.31
1.2
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
268
2292
1.25
2.29
2.9
3.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
759
7281
1.37
2.28
5.6
5.0
mmol/l
6.2
6.0
3.39
726
6556
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
13
4.64
2.27
1.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
52
763
0.66
2.23
4.0
3.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
9
29
3.13
2.23
4.0
2.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
24
130
1.87
2.14
5.5
2.1
%
65.6
62.6
0.24
24
130
(3013512) EKG study
271
2336
1.23
2.14
4.2
4.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
23
123
1.89
2.13
4.7
2.8
—
—
—
0
0
(3000012) Reticulocyte production index
11
43
2.58
2.10
1.1
1.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
25
3.22
2.10
1.0
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
8
26
3.10
2.01
1.7
1.1
—
38.0
—
0
6
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
19
97
1.98
2.01
1.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
24
133
1.83
2.01
1.6
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
32
2.83
2.00
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
32
2.83
2.00
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
117
918
1.32
1.99
1.3
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
60
421
1.46
1.99
2.3
2.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
57
2.30
1.98
1.7
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
202
1.66
1.98
1.5
1.6
iu/ml
0.4
0.1
—
10
40
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
17
84
2.04
1.96
1.4
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
64
2.21
1.95
2.3
2.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
11
4.57
1.94
1.0
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
207
1751
1.24
1.93
4.2
3.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
33
204
1.64
1.91
2.9
3.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
30
181
1.68
1.90
1.4
1.4
—
—
—
0
0
(44790047)
14
65
2.17
1.89
2.2
1.5
—
—
—
0
0
(44806118)
14
65
2.17
1.89
2.2
1.5
—
—
—
0
0
(44790048)
14
65
2.17
1.89
2.2
1.5
—
—
—
0
0
(44790049)
14
65
2.17
1.89
2.2
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
41
269
1.55
1.87
1.3
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
14
66
2.14
1.82
1.5
1.8
u/l
15431.8
7819.3
—
6
19
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
12
4.18
1.82
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
299
0.53
1.81
1.4
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
168
0.41
1.80
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
46
316
1.48
1.72
1.0
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
13
3.86
1.71
2.8
1.5
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
5
13
3.86
1.71
2.8
1.5
%
5.8
4.8
—
5
13
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
90
1.91
1.66
1.6
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
69
2.05
1.65
1.1
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
151
1255
1.25
1.65
1.4
1.3
iu/ml
31.5
37.1
0.30
52
399
(3024869) Neuronal Ab [Presence] in Serum
5
14
3.59
1.61
1.4
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
10
43
2.34
1.60
1.1
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
26
161
1.63
1.54
6.0
2.7
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
15
3.35
1.52
1.0
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
112
908
1.27
1.52
1.3
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
14
73
1.93
1.44
1.5
1.5
%
22.4
28.2
—
8
44
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
5
16
3.14
1.44
1.2
1.3
pmol/l
15.8
14.4
—
5
11
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
15
81
1.87
1.40
2.5
3.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
22
134
1.66
1.40
1.1
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
13
67
1.95
1.39
1.7
1.5
e6/l
2537.0
1892.1
—
7
46
(3004716) Salmonella sp identified in Stool by Organism specific culture
43
307
1.42
1.37
1.4
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
17
2.95
1.36
1.2
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
38
0.00
1.34
0.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
9
42
2.15
1.34
2.6
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
12
61
1.98
1.33
1.8
1.5
e6/l
31661.0
152250.2
—
6
33
(3037121) Protein [Mass/volume] in Urine
34
234
1.47
1.31
1.8
2.2
g/l
0.2
0.3
0.03
22
60
(3011648) Oxygen content in Venous blood
12
62
1.95
1.28
1.8
1.6
%
12.0
10.4
0.65
12
62
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
30
433
0.68
1.26
1.7
1.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
54
408
1.35
1.25
1.3
1.2
u/ml
468.2
207.3
0.32
48
371
(3045788) Cell count panel - Pleural fluid
11
56
1.98
1.22
1.8
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
19
2.64
1.21
2.4
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
29
417
0.68
1.21
3.6
3.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
101
1.70
1.20
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
24
157
1.54
1.18
1.7
1.8
iu/l
4.2
4.7
—
10
55
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
35
0.00
1.15
0.0
1.1
—
—
—
0
0
(4015189)
0
35
0.00
1.15
0.0
2.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
35
0.00
1.15
0.0
2.7
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
5
20
2.51
1.15
2.8
1.3
e9/l
0.1
0.1
—
5
20
(3009542) Hematocrit [Volume Fraction] of Blood
601
6262
0.87
1.15
27.8
14.4
%
39.1
39.4
0.48
448
4012
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
65
1.86
1.14
1.0
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
65
1.86
1.14
3.6
2.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
275
2501
1.15
1.09
5.6
4.0
ug/l
2.6
2.0
1.22
248
2232
(3016038) Potassium [Moles/volume] in Urine
11
59
1.88
1.07
1.1
1.2
mmol/l
30.6
34.0
0.28
11
54
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
33
2.13
1.05
1.0
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
33
2.13
1.05
1.1
1.3
u/l
290.9
203.0
—
7
33
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
82
1.72
1.05
1.4
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
24
162
1.50
1.05
3.3
2.2
g/l
128.2
132.2
0.26
18
117
(3003338) MCHC [Mass/volume]
561
5855
0.88
1.03
34.5
17.5
g/l
330.0
332.0
5.62
556
5818
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
48
1.88
1.00
2.0
1.6
—
—
—
0
0
(4010399)
45
579
0.76
0.98
1.7
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
30
0.00
0.97
0.0
1.3
—
—
—
0
0
(4027681)
7
37
1.90
0.94
1.3
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
172
0.58
0.94
1.8
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
18
118
1.54
0.91
2.1
2.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
104
0.48
0.89
3.0
4.5
umol/l
310.0
361.8
—
5
90
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
32
237
1.36
0.89
1.9
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
42
1.91
0.88
1.1
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
43
1.87
0.87
2.8
2.7
%
13.9
13.4
—
8
43
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
15
227
0.65
0.85
1.5
1.7
mg/l
1.5
5.4
—
10
164
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
11
179
0.61
0.85
1.4
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
6
31
1.94
0.84
3.0
2.4
—
42.9
—
0
12
(3025130) Human papilloma virus identified in Specimen
8
45
1.78
0.84
1.9
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
45
1.78
0.84
1.4
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
183
1649
1.14
0.83
4.7
4.2
kg/l
1.0
1.0
0.12
16
243
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
52
419
1.26
0.81
1.2
1.2
iu/ml
75.0
120.2
1.03
20
171
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
47
1.71
0.81
2.9
1.4
g/l
0.8
1.0
—
8
47
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
58
1.73
0.80
1.0
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
759
7444
1.17
0.76
5.5
5.5
mmol/l
2.5
2.7
5.82
721
6787
(3044290) Cell count panel - Cerebral spinal fluid
21
149
1.42
0.76
1.1
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
54
1.67
0.74
1.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
40
1.76
0.71
1.1
1.3
nmol/l
145.6
148.0
—
7
40
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
26
1.93
0.70
1.2
1.7
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
11
69
1.60
0.68
1.0
1.4
—
32.6
—
0
5
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
27
1.86
0.68
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
27
1.86
0.68
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
27
1.86
0.68
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
27
1.86
0.68
1.2
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
9
59
1.53
0.68
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
136
1220
1.14
0.67
1.4
1.2
u/ml
9.9
13.7
0.32
64
439
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
43
1.63
0.67
3.1
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
37
295
1.27
0.66
1.3
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
174
1588
1.12
0.66
2.1
1.8
nmol/l
1317.1
1185.3
1.11
137
1185
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
78
1.55
0.65
1.0
1.1
u/ml
2.3
6.5
—
6
37
(3023410) Appearance of Cerebral spinal fluid
12
78
1.55
0.65
1.3
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
16
112
1.44
0.64
1.4
1.6
%
54.3
66.1
—
9
73
(3000475) Leukocytes [#/volume] in Synovial fluid
26
199
1.32
0.63
2.2
1.6
e6/l
10618.4
13092.1
0.27
19
148
(3004616) Nuclear Ab [Presence] in Serum
6
104
0.57
0.62
1.5
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
49
1.64
0.62
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
49
1.64
0.62
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
49
1.64
0.62
1.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
30
1.67
0.61
1.0
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
50
1.61
0.61
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
50
1.61
0.61
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
50
1.61
0.61
1.0
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
35
1.72
0.57
1.5
2.7
u/ml
423.7
1229.2
—
6
35
(3021788) Differential panel - Synovial fluid
21
158
1.34
0.57
2.1
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
54
1.49
0.57
1.1
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
54
1.49
0.57
1.1
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
54
1.49
0.57
1.1
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
712
6984
1.12
0.56
4.2
4.3
mmol/l
1.3
1.3
1.76
666
6288
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
87
0.57
0.56
1.2
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
88
0.57
0.56
1.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
88
0.57
0.56
1.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
90
0.55
0.56
1.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
90
0.55
0.56
1.2
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
37
1.63
0.55
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
87
770
1.14
0.55
1.6
1.6
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
23
178
1.30
0.53
1.2
1.2
e6/l
8.3
52.3
0.76
16
150
(3000093) Morphology [Interpretation] in Blood Narrative
9
64
1.41
0.51
1.2
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
64
1.41
0.51
1.1
1.1
—
—
—
0
0
(44813793)
6
41
1.47
0.50
1.0
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
84
750
1.13
0.48
2.6
2.6
ug/l
4.9
7.3
1.35
73
660
(3001019) Free T4 and TSH panel - Serum or Plasma
19
243
0.78
0.46
1.3
1.8
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
7
49
1.43
0.46
1.0
1.6
—
28.0
—
0
5
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
7
49
1.43
0.46
1.0
1.6
—
322.0
—
0
5
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
49
1.43
0.46
1.6
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
51
441
1.17
0.45
3.6
3.5
ph
7.4
7.4
0.53
11
49
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
5
31
1.62
0.43
3.2
6.2
%
76.6
74.6
—
5
25
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
56
1.43
0.42
1.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
87
1.38
0.42
1.1
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
57
1.41
0.42
4.1
3.7
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
0
16
0.00
0.41
0.0
1.1
—
30.3
—
0
11
(40762814) Titanium [Mass/volume] in Blood
0
17
0.00
0.40
0.0
2.2
—
3.3
—
0
8
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
102
0.68
0.39
1.7
2.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
7
104
0.67
0.39
1.7
2.3
mmol/l
3.8
4.1
—
7
104
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
48
421
1.15
0.37
3.4
3.5
mmol/l
1.6
1.9
0.38
30
316
(3039443) Prostate specific Ag panel - Serum or Plasma
8
112
0.71
0.37
1.3
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
42
1.43
0.35
1.2
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
19
154
1.24
0.34
1.6
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
87
0.69
0.33
1.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
90
0.66
0.33
1.2
1.2
—
—
—
0
0
(4024509)
10
74
1.36
0.32
2.2
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
47
1.28
0.32
3.2
2.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
29
337
0.86
0.32
2.9
3.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
41
362
1.14
0.31
1.6
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
53
1.32
0.31
1.9
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
19
157
1.21
0.29
1.1
1.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
7
56
1.25
0.29
2.3
1.3
u/l
46.9
35.1
—
7
38
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
57
1.23
0.29
1.0
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
64
1.25
0.27
1.1
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
45
499
0.90
0.26
2.8
3.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
75
1.20
0.25
1.1
1.1
—
—
—
0
0
(4094501)
24
208
1.16
0.24
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
39
1.28
0.23
1.2
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
79
1.27
0.22
1.8
1.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
11
0.00
0.21
0.0
3.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
11
0.00
0.21
0.0
2.9
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
28.5
—
0
10
(3044009) aPTT.lupus sensitive (LA screen)
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
8
104
0.77
0.21
1.6
2.3
mmol/l
104.1
105.1
—
8
104
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.2
—
1.4
—
0
5
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
735
7293
1.05
0.20
5.0
4.8
mmol/l
4.4
4.6
3.90
696
6675
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
25
222
1.13
0.19
2.0
2.3
ug/min
113.9
64.0
0.40
15
136
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
10
82
1.22
0.17
1.0
1.1
%
122.8
116.7
—
10
75
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
82
1.22
0.17
1.0
1.0
—
—
—
0
0
(4306422)
10
82
1.22
0.17
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
15
129
1.17
0.17
2.4
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
70
1.14
0.16
1.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
16
183
0.87
0.16
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
72
1.11
0.16
1.4
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
727
7222
1.04
0.15
4.7
4.8
mmol/l
1.5
1.5
0.59
686
6572
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
80
1.13
0.15
1.1
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
9
83
1.09
0.14
1.8
1.3
mmol/l
8.3
7.5
—
9
56
(3040151) Glucose [Moles/volume] in Capillary blood
7
87
0.80
0.14
2.7
3.6
mmol/l
6.9
7.8
—
7
68
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
40
372
1.08
0.14
1.1
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
63
663
0.95
0.13
4.5
3.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
9
109
0.82
0.13
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
21
231
0.91
0.12
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
54
512
1.06
0.12
1.2
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
18
198
0.91
0.10
1.6
1.2
u/ml
1.7
9.7
—
8
31
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
207
2031
1.03
0.10
4.6
3.9
%
21.5
24.1
1.73
105
971
(1761482) Bacteria [#/volume] in Urine by Culture
19
207
0.92
0.09
4.4
4.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
35
330
1.06
0.09
1.5
1.7
—
—
—
0
0
(4268621)
6
56
1.07
0.08
2.0
2.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
224
1.07
0.08
2.1
1.4
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
6
71
0.84
0.07
1.0
1.0
ng/l
211.5
377.9
—
6
41
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
266
0.94
0.07
2.0
1.7
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
6
72
0.83
0.07
1.0
1.0
ng/l
25.3
57.2
—
6
40
(3005570) Glucose [Moles/volume] in Urine
7
80
0.87
0.07
2.1
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
94
0.85
0.06
1.0
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
94
0.85
0.06
1.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
95
0.84
0.06
1.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
95
0.84
0.06
1.0
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
26
246
1.06
0.06
2.1
1.9
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
18
193
0.93
0.06
1.6
1.2
u/ml
2.7
3.1
—
6
20
(3014051) Protein [Presence] in Urine by Test strip
17
180
0.94
0.04
2.6
2.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
282
1.03
0.02
1.9
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
94
1.06
0.01
1.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
126
0.95
0.00
1.4
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
71
712
1.00
0.00
2.7
3.0
ng/l
207.0
203.2
0.02
63
658
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
61
0.98
0.00
1.2
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4034850)
26
260
1.00
0.00
15.2
10.8
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
5
56
0.89
0.00
1.0
1.8
—
36.4
—
0
11
(3019174) dRVVT (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
62
0.97
0.00
1.2
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
16.3
—
0
8
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
5
59
0.85
0.00
1.0
1.0
u/ml
2.7
2.9
—
5
29
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_PANCREAS_EXALLC – Benign neoplasm: Pancreas
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).